Jean Claude Gentet

High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study

Fouad Namouni, François Doz, M-L. Tanguy et al. · European Journal of Cancer · 1997 · 172 citations

Medicine, Hematology, Oncology +14

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

Birgit Geoerger, Darren Hargrave, Fabienne Thomas et al. · Neuro-Oncology · 2010 · 159 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study

V. Oyharcabal-Bourden, C Kalifa, Jean Claude Gentet et al. · Journal of Clinical Oncology · 2005 · 150 citations · Full text

Medicine, Oncology, Surgery +17

High-grade glioma in children under 5 years of age: A chemotherapy only approach with the BBSFOP protocol

Christelle Dufour, Jacques Grill, Arielle Lellouch‐Tubiana et al. · European Journal of Cancer · 2006 · 144 citations

Medicine, Oncology, Pediatrics +12

No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.

Odile Oberlin, JL Habrand, J M Zucker et al. · Journal of Clinical Oncology · 1992 · 99 citations

Medicine, Oncology, Surgery +15